Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PVB and ERAS in Elective Breast Surgery
NCT03187080Phase 4Terminated
- Sponsor
- University of Wisconsin–Madison
- Start
- Oct 2017
- Primary completion
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of bupivacaine in postoperative pain, postoperative nausea and vomiting (PONV), sponsored by University of Wisconsin–Madison. Started Oct 2017; status: terminated.
02
Drugs
bupivacaine
03
Conditions
postoperative painpostoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on NCT03187080.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03187080.